Test for Deadly TB Glows Fluorescent
April 28, 2009
University of Pittsburgh researchers have developed a method of adding fluorescence to a bacteriophage that readily infects TB -- an innovation that could shorten time to detection.
"Clinicians need rapid, relatively cheap and simple methods for detecting TB and drug-resistant strains in the local clinic," said study co-author William R. Jacobs Jr. of the Albert Einstein College of Medicine.
The deadly co-epidemics of HIV and drug-resistant TB in Tugela Ferry in South Africa's KwaZulu-Natal province highlight "a dire and desperate need" for a new diagnostic tool, said Graham F. Hatfull, chair of the Department of Biological Sciences at University of Pittsburgh's School of Arts and Sciences. Patients coinfected with HIV and XDR TB have a median life expectancy of only 16 days and the combination of infections is almost 100 percent fatal. "This problem is more widespread than people realize," he said.
The new diagnostic tool will likely take two years before it is ready for use in the field.
The study, "Fluoromycobacteriophages for Rapid, Specific, and Sensitive Antibiotic Susceptibility Testing of Mycobacterium tuberculosis," was published online in the open-access journal Public Library of Sciences ONE (2009;4(3): e4870. doi:10.1371/journal/pone.0004870).
04.22.2009; David Templeton
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.